研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2020 年的期刊文章 · 第 4 页
共 1467 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2020-11-24 到 2020-11-10。
按期刊、按主题看 →
JASA Latent Variables & Mixtures Networks & Graphs · 发表于 2020-11-24
Tianxi Li, Lihua Lei, Sharmodeep Bhattacharyya, Koen Van den Berge, Purnamrita Sarkar, Peter J. Bickel, Elizaveta Levina
摘要
The problem of community detection in networks is usually formulated as finding a single partition of the network into some “correct” number of communities. We argue that it is more interpretable and in some regimes more accurate to construct a hierarchical tree of communities instead. This can be done with a simple top-down recursive partitioning algorithm, starting with a single community and separating the nodes into two communities by spectral clustering repeatedly, until a stopping rule suggests there are no further communities. This class of algorithms is model-free, computationally efficient, and requires no tuning other than selecting a stopping rule. We show that there are regimes where this approach outperforms K-way spectral clustering, and propose a natural framework for analyzing the algorithm’s theoretical performance, the binary tree stochastic block model. Under this model, we prove that the algorithm correctly recovers the entire community tree under relatively mild assumptions. We apply the algorithm to a gene network based on gene co-occurrence in 1580 research papers on anemia, and identify six clusters of genes in a meaningful hierarchy. We also illustrate the algorithm on a dataset of statistics papers. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
SMMR Latent Variables & Mixtures Clinical Trials · 发表于 2020-11-24
Martina McMenamin, Jessica K Barrett, Anna Berglind, James MS Wason
摘要
Composite endpoints that combine multiple outcomes on different scales are common in clinical trials, particularly in chronic conditions. In many of these cases, patients will have to cross a predefined responder threshold in each of the outcomes to be classed as a responder overall. One instance of this occurs in systemic lupus erythematosus, where the responder endpoint combines two continuous, one ordinal and one binary measure. The overall binary responder endpoint is typically analysed using logistic regression, resulting in a substantial loss of information. We propose a latent variable model for the systemic lupus erythematosus endpoint, which assumes that the discrete outcomes are manifestations of latent continuous measures and can proceed to jointly model the components of the composite. We perform a simulation study and find that the method offers large efficiency gains over the standard analysis, the magnitude of which is highly dependent on the components driving response. Bias is introduced when joint normality assumptions are not satisfied, which we correct for using a bootstrap procedure. The method is applied to the Phase IIb MUSE trial in patients with moderate to severe systemic lupus erythematosus. We show that it estimates the treatment effect 2.5 times more precisely, offering a 60% reduction in required sample size.
SiM Longitudinal Data Survival Analysis · 发表于 2020-11-23
Eghbal Zandkarimi, Abbas Moghimbeigi, Hossein Mahjub
摘要
A popular method for simultaneously modeling of correlated count response with excess zeros and time to event is by means of the joint models. In these models, the likelihood‐based methods (such as expectation‐maximization algorithm and Newton‐Raphson) are used for estimating the parameters, but in the presence of contaminations, these methods are unstable. To overcome this challenge, we extend the M‐estimator methods and propose a robust estimator approach to obtain a robust estimation of the regression parameters in the joint model. Our proposed algorithm has two steps (Expectation and Solution). In the expectation step, the likelihood function is expected by conditioning on the observed data and in the solution step, the parameters are computed, with solving robust estimating equations. Therefore, this algorithm achieves robustness by applying robust estimating equations and weighted likelihood in the S‐step. Simulation studies under various situations of contaminations show that the robust algorithm gives us consistent estimates with a smaller bias than likelihood‐based methods. The application section uses data on factors affecting fertility and birth spacing.
SiM Survival Analysis · 发表于 2020-11-23
Zhong Guan
摘要
Maximum approximate Bernstein likelihood estimates of the baseline density function and the regression coefficients in the proportional hazard regression models based on interval‐censored event time data result in smooth estimates of the survival functions which enjoys an almost n1/2‐rate of convergence faster than the n1/3‐rate for the existing estimates. The proposed method was shown by a simulation to have better finite sample performance than its main competitors. Some examples including real data are used to illustrate the usage of the proposed method.
Biometrics Causal Inference · 发表于 2020-11-22
Ariel Alonso, Wim Van der Elst, Lizet Sanchez, Patricia Luaces, Geert Molenberghs
摘要
Given the heterogeneous responses to therapy and the high cost of treatments, there is an increasing interest in identifying pretreatment predictors of therapeutic effect. Clearly, the success of such an endeavor will depend on the amount of information that the patient‐specific variables convey about the individual causal treatment effect on the response of interest. In the present work, using causal inference and information theory, a strategy is proposed to evaluate individual predictive factors for cancer immunotherapy efficacy. In a first step, the methodology proposes a causal inference model to describe the joint distribution of the pretreatment predictors and the individual causal treatment effect. Further, in a second step, the so‐called predictive causal information (PCI), a metric that quantifies the amount of information the pretreatment predictors convey on the individual causal treatment effects, is introduced and its properties are studied. The methodology is applied to identify predictors of therapeutic success for a therapeutic vaccine in advanced lung cancer. A user‐friendly R library EffectTreat is provided to carry out the necessary calculations.
SiM High-Dimensional Genetics & Omics Diagnostics & Prediction · 发表于 2020-11-20
Lihui Liu, Hong Gu, Johan Van Limbergen, Toby Kenney
摘要
In this article, we present a new variable selection method for regression and classification purposes, particularly for microbiome analysis. Our method, called subsampling ranking forward selection (SuRF), is based on LASSO penalized regression, subsampling and forward‐selection methods. SuRF offers major advantages over existing variable selection methods in terms of both sparsity of selected models and model inference. We provide anRpackage that can implement our method for generalized linear models. We apply our method to classification problems from microbiome data, using a novel agglomeration approach to deal with the special tree‐like correlation structure of the variables. Existing methods arbitrarily choose a taxonomic level a priori before performing the analysis, whereas by combining SuRF with these aggregated variables, we are able to identify the key biomarkers at the appropriate taxonomic level, as suggested by the data. We present simulations in multiple sparse settings to demonstrate that our approach performs better than several other popularly used existing approaches in recovering the true variables. We apply SuRF to two microbiome datasets: one about prediction of pouchitis and another for identifying samples from two healthy individuals. We find that SuRF can provide a better or comparable prediction with other methods while controlling the false positive rate of variable selection.
SiM Causal Inference · 发表于 2020-11-20
Paul Meyvisch, Ariel Alonso, Wim Van der Elst, Geert Molenberghs
摘要
The relationship between association and surrogacy has been the focus of much debate in the surrogate marker literature. Recently, the individual causal association (ICA) has been introduced as a metric of surrogacy in the causal inference framework, when both the surrogate and the true endpoint are normally distributed and when both are binary. Earlier work on the normal case has demonstrated that, although the ICA and the adjusted association are related metrics, their relationship strongly depends on unidentifiable parameters and, consequently, the association between both endpoints conveys little information on the validity of the surrogate. In addition, in the normal setting, the magnitude of the ICA does not depend on the mean of the outcomes. The latter implies that identifiable parameters such as mean responses and treatment effects provide no information on the validity of the surrogate. In the present work it is shown that this is fundamentally different in the binary case. We demonstrate that the observed association between the outcomes as well as the success rates in both treatment groups are quite predictive for the ICA. It is shown that finding a good surrogate will be more likely when the association between the endpoints is large, there are sizeable treatment effects and the success rates for both endpoints are similar in both treatment groups. These results are demonstrated using extensive simulations and illustrated on a case study in multi‐drug resistant tuberculosis.
SiM Spatial & Time Series · 发表于 2020-11-20
Oana Petrof, Thomas Neyens, Valerie Nuyts, Kristiaan Nackaerts, Benoit Nemery, Christel Faes
摘要
Mesothelioma is a rare cancer caused by exposure to asbestos. Belgium has a known long history of asbestos production, resulting in one of the highest mesothelioma mortality rates worldwide. While the production of asbestos has stopped completely, the long latency period of mesothelioma, which can fluctuate between 20 and 40 years after exposure, causes incidences still to be frequent. Mesothelioma's long incubation time affects our assessment of its geographical distribution as well. Since patients' residential locations are likely to change a number of times throughout their lives, the location where the patients develop the disease is often far from the location where they were exposed to asbestos. Using the residential history of patients, we propose the use of a convolution multiple membership model (MMM), which includes both a spatial conditional autoregressive and an unstructured random effect. Pancreatic cancer patients are used as a control population, reflecting the population at risk for mesothelioma. Results show the impact of the residential mobility on the geographical risk estimation, as well as the importance of acknowledging the latency period of a disease. A simulation study was conducted to investigate the properties of the convolution MMM. The robustness of the results for the convolution MMM is assessed via a sensitivity analysis.
JASA Survival Analysis Genetics & Omics · 发表于 2020-11-20
Malka Gorfine, Nir Keret, Asaf Ben Arie, David Zucker, Li Hsu
摘要
The UK Biobank is a large-scale health resource comprising genetic, environmental, and medical information on approximately 500,000 volunteer participants in the United Kingdom, recruited at ages 40–69 during the years 2006–2010. The project monitors the health and well-being of its participants. This work demonstrates how these data can be used to yield the building blocks for an interpretable risk-prediction model, in a semiparametric fashion, based on known genetic and environmental risk factors of various chronic diseases, such as colorectal cancer. An illness-death model is adopted, which inherently is a semi-competing risks model, since death can censor the disease, but not vice versa. Using a shared-frailty approach to account for the dependence between time to disease diagnosis and time to death, we provide a new illness-death model that assumes Cox models for the marginal hazard functions. The recruitment procedure used in this study introduces delayed entry to the data. An additional challenge arising from the recruitment procedure is that information coming from both prevalent and incident cases must be aggregated. Lastly, we do not observe any deaths prior to the minimal recruitment age, 40. In this work, we provide an estimation procedure for our new illness-death model that overcomes all the above challenges. Supplementary materials for this article, including a standardized description of the materials available for reproducing the work, are available as an online supplement. *(abstract via OpenAlex)*
JASA Latent Variables & Mixtures · 发表于 2020-11-20
Jianqing Fan, Yuan Liao
摘要
Estimations and applications of factor models often rely on the crucial condition that the number of latent factors is consistently estimated, which in turn also requires that factors be relatively strong, data are stationary and weakly serially dependent, and the sample size be fairly large, although in practical applications, one or several of these conditions may fail. In these cases, it is difficult to analyze the eigenvectors of the data matrix. To address this issue, we propose simple estimators of the latent factors using cross-sectional projections of the panel data, by weighted averages with predetermined weights. These weights are chosen to diversify away the idiosyncratic components, resulting in “diversified factors.” Because the projections are conducted cross-sectionally, they are robust to serial conditions, easy to analyze and work even for finite length of time series. We formally prove that this procedure is robust to over-estimating the number of factors, and illustrate it in several applications, including post-selection inference, big data forecasts, large covariance estimation, and factor specification tests. We also recommend several choices for the diversified weights. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
SiM Bayesian Methods Clinical Trials · 发表于 2020-11-20
Fang Fang, Kimberly A. Hochstedler, Roy N. Tamura, Thomas M. Braun, Kelley M. Kidwell
摘要
Clinical trials studying treatments for rare diseases are challenging to design and conduct due to the limited number of patients eligible for the trial. One design used to address this challenge is the small n, sequential, multiple assignment, randomized trial (snSMART). We propose a new snSMART design that investigates the response rates of a drug tested at a low and high dose compared with placebo. Patients are randomized to an initial treatment (stage 1). In stage 2, patients are rerandomized, depending on their initial treatment and their response to that treatment in stage 1, to either the same or a different dose of treatment. Data from both stages are used to determine the efficacy of the active treatment. We present a Bayesian approach where information is borrowed between stage 1 and stage 2. We compare our approach to standard methods using only stage 1 data and a log‐linear Poisson model that uses data from both stages where parameters are estimated using generalized estimating equations. We observe that the Bayesian method has smaller root‐mean‐square‐error and 95% credible interval widths than standard methods in the tested scenarios. We conclude that it is advantageous to utilize data from both stages for a primary efficacy analysis and that the specific snSMART design shown here can be used in the registration of a drug for the treatment of rare diseases.
JASA Genetics & Omics · 发表于 2020-11-20
Yaowu Liu, Zilin Li, Xihong Lin
摘要
Testing a global hypothesis for a set of variables is a fundamental problem in statistics with a wide range of applications. A few well-known classical tests include the Hotelling's T 2 test, the F test, and the empirical Bayes based score test. These classical tests, however, are not robust to the signal strength and could have a substantial loss of power when signals are weak or moderate, a situation we commonly encounter in contemporary applications. In this paper, we propose a Minimax Optimal Ridge-type Set Test (MORST), a simple and generic method for testing a global hypothesis. The power of MORST is robust and considerably higher than that of the classical tests when the strength of signals is weak or moderate. In the meantime, MORST only requires a slight increase in computation compared to these existing tests, making it applicable to the analysis of massive genome-wide data. We also provide the generalizations of MORST that are parallel to the traditional Wald test and Rao's score test in asymptotic settings. Extensive simulations demonstrated the robust power of MORST and that the type I error of MORST was well controlled. We applied MORST to the analysis of the whole-genome sequencing data from the Atherosclerosis Risk in Communities (ARIC) study, where MORST detected 20%-250% more signal regions than the classical tests. *(abstract via PubMed)*
JASA Other · 发表于 2020-11-19
Lazhi Wang, David E. Jones, Xiao-Li Meng
摘要
Bridge sampling is an effective Monte Carlo (MC) method for estimating the ratio of normalizing constants of two probability densities, a routine computational problem in statistics, physics, chemistry, and other fields. The MC error of the bridge sampling estimator is determined by the amount of overlap between the two densities. In the case of unimodal densities, Warp-I, II, and III transformations are effective for increasing the initial overlap, but they are less so for multimodal densities. This article introduces Warp-U transformations that aim to transform multimodal densities into unimodal ones (hence “U”) without altering their normalizing constants. The construction of a Warp-U transformation starts with a normal (or other convenient) mixture distribution ϕmix that has reasonable overlap with the target density p, whose normalizing constant is unknown. The stochastic transformation that maps ϕmix back to its generating distribution N(0,1) is then applied to p yielding its Warp-U version, which we denote p˜. Typically, p˜ is unimodal and has substantially increased overlap with ϕ. Furthermore, we prove that the overlap between p˜ and N(0,1) is guaranteed to be no less than the overlap between p and ϕmix, in terms of any f-divergence. We propose a computationally efficient method to find an appropriate ϕmix, and a simple but effective approach to remove the bias which results from estimating the normalizing constant and fitting ϕmix with the same data. We illustrate our findings using 10 and 50 dimensional highly irregular multimodal densities, and demonstrate how Warp-U sampling can be used to improve the final estimation step of the Generalized Wang–Landau algorithm, a powerful sampling and estimation approach. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
SMMR Causal Inference · 发表于 2020-11-19
Tao Liu, Joseph W Hogan
摘要
Confounding is a major concern when using data from observational studies to infer the causal effect of a treatment. Instrumental variables, when available, have been used to construct bound estimates on population average treatment effects when outcomes are binary and unmeasured confounding exists. With continuous outcomes, meaningful bounds are more challenging to obtain because the domain of the outcome is unrestricted. In this paper, we propose to unify the instrumental variable and inverse probability weighting methods, together with suitable assumptions in the context of an observational study, to construct meaningful bounds on causal treatment effects. The contextual assumptions are imposed in terms of the potential outcomes that are partially identified by data. The inverse probability weighting component incorporates a sensitivity parameter to encode the effect of unmeasured confounding. The instrumental variable and inverse probability weighting methods are unified using the principal stratification. By solving the resulting system of estimating equations, we are able to quantify both the causal treatment effect and the sensitivity parameter (i.e. the degree of the unmeasured confounding). We demonstrate our method by analyzing data from the HIV Epidemiology Research Study.
JASA Optimization & Learning Theory · 发表于 2020-11-19
Haoyu Chen, Wenbin Lu, Rui Song
摘要
Online decision making aims to learn the optimal decision rule by making personalized decisions and updating the decision rule recursively. It has become easier than before with the help of big data, but new challenges also come along. Since the decision rule should be updated once per step, an offline update which uses all the historical data is inefficient in computation and storage. To this end, we propose a completely online algorithm that can make decisions and update the decision rule online via stochastic gradient descent. It is not only efficient but also supports all kinds of parametric reward models. Focusing on the statistical inference of online decision making, we establish the asymptotic normality of the parameter estimator produced by our algorithm and the online inverse probability weighted value estimator we used to estimate the optimal value. Online plugin estimators for the variance of the parameter and value estimators are also provided and shown to be consistent, so that interval estimation and hypothesis test are possible using our method. The proposed algorithm and theoretical results are tested by simulations and a real data application to news article recommendation. *(abstract via OpenAlex)*
JASA Other · 发表于 2020-11-19
Koen Jochmans
摘要
We consider inference in linear regression models that is robust to heteroscedasticity and the presence of many control variables. When the number of control variables increases at the same rate as the sample size the usual heteroscedasticity-robust estimators of the covariance matrix are inconsistent. Hence, tests based on these estimators are size distorted even in large samples. An alternative covariance-matrix estimator for such a setting is presented that complements recent work by Cattaneo, Jansson, and Newey. We provide high-level conditions for our approach to deliver (asymptotically) size-correct inference as well as more primitive conditions for three special cases. Simulation results and an empirical illustration to inference on the union premium are also provided. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
Biometrika Survival Analysis · 发表于 2020-11-19
Huijuan Ma, Limin Peng, Chiung-Yu Huang, Haoda Fu
摘要
Summary: Progression of chronic disease is often manifested by repeated occurrences of disease-related events over time. Delineating the heterogeneity in the risk of such recurrent events can provide valuable scientific insight for guiding customized disease management. We propose a new sensible measure of individual risk of recurrent events and present a dynamic modelling framework thereof, which accounts for both observed covariates and unobservable frailty. The proposed modelling requires no distributional specification of the unobservable frailty, while permitting exploration of the dynamic effects of the observed covariates. We develop estimation and inference procedures for the proposed model through a novel adaptation of the principle of conditional score. The asymptotic properties of the proposed estimator, including the uniform consistency and weak convergence, are established. Extensive simulation studies demonstrate satisfactory finite-sample performance of the proposed method. We illustrate the practical utility of the new method via an application to a diabetes clinical trial that explores the risk patterns of hypoglycemia in type 2 diabetes patients.
JASA Other · 发表于 2020-11-19
Jianqing Fan, Jianhua Guo, Shurong Zheng
摘要
Determining the number of common factors is an important and practical topic in high-dimensional factor models. The existing literature is mainly based on the eigenvalues of the covariance matrix. Owing to the incomparability of the eigenvalues of the covariance matrix caused by the heterogeneous scales of the observed variables, it is not easy to find an accurate relationship between these eigenvalues and the number of common factors. To overcome this limitation, we appeal to the correlation matrix and demonstrate, surprisingly, that the number of eigenvalues greater than 1 of the population correlation matrix is the same as the number of common factors under certain mild conditions. To use such a relationship, we study random matrix theory based on the sample correlation matrix to correct biases in estimating the top eigenvalues and to take into account of estimation errors in eigenvalue estimation. Thus, we propose a tuning-free scale-invariant adjusted correlation thresholding (ACT) method for determining the number of common factors in high-dimensional factor models, taking into account the sampling variabilities and biases of top sample eigenvalues. We also establish the optimality of the proposed ACT method in terms of minimal signal strength and the optimal threshold. Simulation studies lend further support to our proposed method and show that our estimator outperforms competing methods in most test cases. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
SiM Survival Analysis · 发表于 2020-11-18
Paramita Saha‐Chaudhuri, Lamin Juwara
摘要
For a continuous time‐to‐event outcome and an expensive‐to‐measure exposure, we develop a pooling design and propose a likelihood‐based approach to estimate the hazard ratios (HRs) of a Cox proportional hazards (PH) model. Our proposed approach fits a PH model based on pooled exposures with individually observed time‐to‐event outcomes. The design and estimation exploits the equivalence of the conditional logistic likelihood functions arising from a matched case‐control study and the partial likelihood function of a riskset‐matched, nested case‐control (NCC) subset of a cohort study. To create the pools, we first focus on an NCC subcohort. Pools are formed at random while keeping the matching intact. Pool‐level exposure and confounders are then evaluated and used in the likelihood to estimate the HR and the standard error of the estimates. The estimators are MLEs, provide consistent estimates of the individual‐level HRs, and are asymptotically normal. Our simulation results indicate that the pooled estimates are comparable to the estimates obtained from the NCC subcohort. The units of analysis for the pooled design are the pools and not the individual participants. Hence the effective sample size is reduced. Therefore, the variance of the HR estimate increases with increasing poolsize. However, this variance inflation in small samples can be offset by including more matched controls per case within the NCC subcohort. An application is demonstrated with the Second Manifestations of ARTerial disease (SMART) study.
SiM Diagnostics & Prediction · 发表于 2020-11-18
Yougui Wu
摘要
Statistical methods are well developed for estimating the area under the receiver operating characteristic curve (AUC) based on a random sample where the gold standard is available for every subject in the sample, or a two‐phase sample where the gold standard is ascertained only at the second phase for a subset of subjects sampled using fixed sampling probabilities. However, the methods based on a two‐phase sample do not attempt to optimize the sampling probabilities to minimize the variance of AUC estimator. In this paper, we consider the optimal two‐phase sampling design for evaluating the performance of an ordinal test in classifying disease status. We derived the analytic variance formula for the AUC estimator and used it to obtain the optimal sampling probabilities. The efficiency of the two‐phase sampling under the optimal sampling probabilities (OA) is evaluated by a simulation study, which indicates that two‐phase sampling under OA achieves a substantial amount of variance reduction with an over‐sample of subjects with low and high ordinal levels, compared with two‐phase sampling under proportional allocation (PA). Furthermore, in comparison with an one‐phase random sampling, two‐phase sampling under OA or PA have a clear advantage in reducing the variance of AUC estimator when the variance of diagnostic test results in the disease population is small relative to its counterpart in nondisease population. Finally, we applied the optimal two‐phase sampling design to a real‐world example to evaluate the performance of a questionnaire score in screening for childhood asthma.
SiM Clinical Trials · 发表于 2020-11-18
Michael J. Martens, Brent R. Logan
摘要
To ensure that a study can properly address its research aims, the sample size and power must be determined appropriately. Covariate adjustment via regression modeling permits more precise estimation of the effect of a primary variable of interest at the expense of increased complexity in sample size/power calculation. The presence of correlation between the main variable and other covariates, commonly seen in observational studies and non‐randomized clinical trials, further complicates this process. Though sample size and power specification methods have been obtained to accommodate specific covariate distributions and models, most existing approaches rely on either simple approximations lacking theoretical support or complex procedures that are difficult to apply at the design stage. The current literature lacks a general, coherent theory applicable to a broader class of regression models and covariate distributions. We introduce succinct formulas for sample size and power determination with the generalized linear, Cox, and Fine‐Gray models that account for correlation between a main effect and other covariates. Extensive simulations demonstrate that this method produces studies that are appropriately sized to meet their type I error rate and power specifications, particularly offering accurate sample size/power estimation in the presence of correlated covariates.
SiM High-Dimensional · 发表于 2020-11-18
Wenjiang Fu, Junyu Ding, Kuikui Gao, Shuangge Ma, Lu Tian
摘要
In this article, we introduce the recently developed intrinsic estimator method in the age‐period‐cohort (APC) models in examining disease incidence and mortality data, further develop a likelihood ratio (L‐R) test for testing differences in temporal trends across populations, and apply the methods to examining temporal trends in the age, period or calendar time, and birth cohort of the US heart disease mortality across racial and sex groups. The temporal trends are estimated with the intrinsic estimator method to address the model identification problem, in which multiple sets of parameter estimates yield the same fitted values for a given dataset, making it difficult to conduct comparison of and hypothesis testing on the temporal trends in the age, period, and cohort across populations. We employ a penalized profile log‐likelihood approach in developing the L‐R test to deal with the issues of multiple estimators and the diverging number of model parameters. The identification problem also induces overparametrization of the APC model, which requires a correction of the degree of freedom of the L‐R test. Monte Carlo simulation studies demonstrate that the L‐R test performs well in the Type I error calculation and is powerful to detect differences in the age or period trends. The L‐R test further reveals disparities of heart disease mortality among the US populations and between the US and Japanese populations.
SiM Genetics & Omics Causal Inference · 发表于 2020-11-17
Haixiang Zhang, Jun Chen, Yang Feng, Chan Wang, Huilin Li, Lei Liu
摘要
The microbiome plays an important role in human health by mediating the path from environmental exposures to health outcomes. The relative abundances of the high‐dimensional microbiome data have an unit‐sum restriction, rendering standard statistical methods in the Euclidean space invalid. To address this problem, we use the isometric log‐ratio transformations of the relative abundances as the mediator variables. To select significant mediators, we consider a closed testing‐based selection procedure with desirable confidence. Simulations are provided to verify the effectiveness of our method. As an illustrative example, we apply the proposed method to study the mediation effects of murine gut microbiome between subtherapeutic antibiotic treatment and body weight gain, and identify Coprobacillus and Adlercreutzia as two significant mediators.
SiM Genetics & Omics · 发表于 2020-11-17
Seongyoon Kim, Sanghee Lee, Jung‐Il Choi, Hyunsoon Cho
摘要
The joinpoint regression model (JRM) is used to describe trend changes in many applications and relies on the detection of joinpoints (changepoints). However, the existing joinpoint detection methods, namely, the grid search (GS)‐based methods, are computationally demanding, and hence, the maximum number of computable joinpoints is limited. Herein, we developed a genetic algorithm‐based joinpoint (GAJP) model in which an explicitly decoupled computing procedure for optimization and regression is used to embed a binary genetic algorithm into the JRM for optimal joinpoint detection. The combinations of joinpoints were represented as binary chromosomes, and genetic operations were performed to determine the optimum solution by minimizing the fitness function, the Bayesian information criterion (BIC) and BIC 3 . The accuracy and computational performance of the GAJP model were evaluated via intensive simulation studies and compared with those of the GS‐based methods using BIC, BIC 3 , and permutation test. The proposed method showed an outstanding computational efficiency in detecting multiple joinpoints. Finally, the suitability of the GAJP model for the analysis of cancer incidence trends was demonstrated by applying this model to data on the incidence of colorectal cancer in the United States from 1975 to 2016 from the National Cancer Institute's Surveillance, Epidemiology, and End Results program. Thus, the GAJP model was concluded to be practically feasible to detect multiple joinpoints up to the number of grids without requirement to preassign the number of joinpoints and be easily extendable to cancer trend analysis utilizing large datasets.
Biometrika Survival Analysis · 发表于 2020-11-16
K Garside, A Gjoka, R Henderson, H Johnson, I Makarenko
摘要
Summary: Persistent homology is used to track the appearance and disappearance of features as we move through a nested sequence of topological spaces. Equating the nested sequence to a filtration and the appearance and disappearance of features to events, we show that simple event history methods can be used for the analysis of topological data. We propose a version of the well-known Nelson–Aalen cumulative hazard estimator for the comparison of topological features of random fields and for testing parametric assumptions. We suggest a Cox proportional hazards approach for the analysis of embedded metric trees. The Nelson–Aalen method is illustrated on globally distributed climate data and on neutral hydrogen distribution in the Milky Way. The Cox method is used to compare vascular patterns in fundus images of the eyes of healthy and diabetic retinopathy patients.
JASA Genetics & Omics · 发表于 2020-11-12
Zilin Li, Yaowu Liu, Xihong Lin
摘要
We consider in this paper detection of signal regions associated with disease outcomes in whole genome association studies. Gene- or region-based methods have become increasingly popular in whole genome association analysis as a complementary approach to traditional individual variant analysis. However, these methods test for the association between an outcome and the genetic variants in a pre-specified region, e.g., a gene. In view of massive intergenic regions in whole genome sequencing (WGS) studies, we propose a computationally efficient quadratic scan (Q-SCAN) statistic based method to detect the existence and the locations of signal regions by scanning the genome continuously. The proposed method accounts for the correlation (linkage disequilibrium) among genetic variants, and allows for signal regions to have both causal and neutral variants, and the effects of signal variants to be in different directions. We study the asymptotic properties of the proposed Q-SCAN statistics. We derive an empirical threshold that controls for the family-wise error rate, and show that under regularity conditions the proposed method consistently selects the true signal regions. We perform simulation studies to evaluate the finite sample performance of the proposed method. Our simulation results show that the proposed procedure outperforms the existing methods, especially when signal regions have causal variants whose effects are in different directions, or are contaminated with neutral variants. We illustrate Q-SCAN by analyzing the WGS data from the Atherosclerosis Risk in Communities study. *(abstract via PubMed)*
JASA Machine Learning High-Dimensional Optimization & Learning Theory · 发表于 2020-11-12
Naim U. Rashid, Daniel J. Luckett, Jingxiang Chen, Michael T. Lawson, Longshaokan Wang, Yunshu Zhang, Eric B. Laber, Yufeng Liu, Jen Jen Yeh, Donglin Zeng, Michael R. Kosorok
摘要
The complexity of human cancer often results in significant heterogeneity in response to treatment. Precision medicine offers the potential to improve patient outcomes by leveraging this heterogeneity. Individualized treatment rules (ITRs) formalize precision medicine as maps from the patient covariate space into the space of allowable treatments. The optimal ITR is that which maximizes the mean of a clinical outcome in a population of interest. Patient-derived xenograft (PDX) studies permit the evaluation of multiple treatments within a single tumor, and thus are ideally suited for estimating optimal ITRs. PDX data are characterized by correlated outcomes, a high-dimensional feature space, and a large number of treatments. Here we explore machine learning methods for estimating optimal ITRs from PDX data. We analyze data from a large PDX study to identify biomarkers that are informative for developing personalized treatment recommendations in multiple cancers. We estimate optimal ITRs using regression-based (Q-learning) and direct-search methods (outcome weighted learning). Finally, we implement a superlearner approach to combine multiple estimated ITRs and show that the resulting ITR performs better than any of the input ITRs, mitigating uncertainty regarding user choice. Our results indicate that PDX data are a valuable resource for developing individualized treatment strategies in oncology. Supplementary materials for this article are available online. *(abstract via PubMed)*
SiM Testing & Uncertainty · 发表于 2020-11-12
Lifeng Lin, Ariel M. Aloe
摘要
Meta‐analyses of a treatment's effect compared with a control frequently calculate the meta‐effect from standardized mean differences (SMDs). SMDs are usually estimated by Cohen's d or Hedges' g . Cohen's d divides the difference between sample means of a continuous response by the pooled standard deviation, but is subject to nonnegligible bias for small sample sizes. Hedges' g removes this bias with a correction factor. The current literature (including meta‐analysis books and software packages) is confusingly inconsistent about methods for synthesizing SMDs, potentially making reproducibility a problem. Using conventional methods, the variance estimate of SMD is associated with the point estimate of SMD, so Hedges' g is not guaranteed to be unbiased in meta‐analyses. This article comprehensively reviews and evaluates available methods for synthesizing SMDs. Their performance is compared using extensive simulation studies and analyses of actual datasets. We find that because of the intrinsic association between point estimates and standard errors, the usual version of Hedges' g can result in more biased meta‐estimation than Cohen's d . We recommend using average‐adjusted variance estimators to obtain an unbiased meta‐estimate, and the Hartung‐Knapp‐Sidik‐Jonkman method for accurate estimation of its confidence interval.
JASA Bayesian Methods Causal Inference Nonparametric & Semiparametric · 发表于 2020-11-12
Maxime Rischard, Zach Branson, Luke Miratrix, Luke Bornn
摘要
What is the premium on house price for a particular school district? To estimate this in New York City we use a novel implementation of a geographic regression discontinuity design (GeoRDD) built from Gaussian processes regression (kriging) to model spatial structure. With a GeoRDD, we specifically examine price differences along borders between “treatment” and “control” school districts. GeoRDDs extend RDDs to multivariate settings; location is the forcing variable and the border between school districts constitutes the discontinuity threshold. We first obtain a Bayesian posterior distribution of the price difference function, our nominal treatment effect, along the border. We then address nuances of having a functional estimand defined on a border with potentially intricate topology, particularly when defining and estimating causal estimands of the local average treatment effect (LATE). We test for nonzero LATE with a calibrated hypothesis test with good frequentist properties, which we further validate using a placebo test. Using our methodology, we identify substantial differences in price across several borders. In one case, a border separating Brooklyn and Queens, we estimate a statistically significant 20% higher price for a house on the more desirable side. We also find that geographic features can undermine some of these comparisons. Supplementary materials for this article, including a standardized description of the materials available for reproducing the work, are available as an online supplement. *(abstract via OpenAlex)*
JASA Bayesian Methods · 发表于 2020-11-12
Yan Dora Zhang, Brian P. Naughton, Howard D. Bondell, Brian J. Reich
摘要
Prior distributions for high-dimensional linear regression require specifying a joint distribution for the unobserved regression coefficients, which is inherently difficult. We instead propose a new class of shrinkage priors for linear regression via specifying a prior first on the model fit, in particular, the coefficient of determination, and then distributing through to the coefficients in a novel way. The proposed method compares favorably to previous approaches in terms of both concentration around the origin and tail behavior, which leads to improved performance both in posterior contraction and in empirical performance. The limiting behavior of the proposed prior is 1/x , both around the origin and in the tails. This behavior is optimal in the sense that it simultaneously lies on the boundary of being an improper prior both in the tails and around the origin. None of the existing shrinkage priors obtain this behavior in both regions simultaneously. We also demonstrate that our proposed prior leads to the same near-minimax posterior contraction rate as the spike-and-slab prior. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
JASA Clinical Trials · 发表于 2020-11-12
Yang Liu, Feifang Hu
摘要
Balancing important covariates is often critical in clinical trials and causal inference. Stratified permuted block (STR-PB) and covariate-adaptive randomization (CAR) procedures are widely used to balance observed covariates in practice. The balance properties of these procedures with respect to the observed covariates have been well studied. However, it has been questioned whether these methods will also yield a good balance for the unobserved covariates. In this article, we develop a general framework for the analysis of the unobserved covariates imbalance. These results are applicable to develop and compare the balance properties of complete randomization (CR), STR-PB, and CAR procedures with respect to the unobserved covariates. To quantify the improvement obtained by using STR-PB and CAR procedures rather than CR, we introduce the percentage reduction in variance of the unobserved covariates imbalance and compare these quantities. Our results demonstrate the benefits of using CAR or STR-PB (when the number of strata is small relative to the sample size) in terms of balancing unobserved covariates. These results also pave the way for future research into the effect of unobserved covariates in covariate-adaptive randomized experiments in clinical trials, as well as many other applications. Supplementary materials for this article are available online. *(abstract via OpenAlex)*
SiM Functional Data Longitudinal Data Missing Data & Measurement Error · 发表于 2020-11-11
Haolun Shi, Jianghu Dong, Liangliang Wang, Jiguo Cao
摘要
In longitudinal studies, the values of biomarkers are often informatively missing due to dropout. The conventional functional principal component analysis typically disregards the missing information and simply treats the unobserved data points as missing completely at random. As a result, the estimation of the mean function and the covariance surface might be biased, resulting in a biased estimation of the functional principal components. We propose the informatively missing functional principal component analysis (imFunPCA), which is well suited for cases where the longitudinal trajectories are subject to informative missingness. Computation of the functional principal components in our approach is based on the likelihood of the data, where information of both the observed and missing data points are incorporated. We adopt a regression‐based orthogonal approximation method to decompose the latent stochastic process based on a set of orthonormal empirical basis functions. Under the case of informative missingness, we show via simulation studies that the performance of our approach is superior to that of the conventional ones. We apply our method on a longitudinal dataset of kidney glomerular filtration rates for patients post renal transplantation.
SMMR Longitudinal Data Latent Variables & Mixtures Nonparametric & Semiparametric · 发表于 2020-11-11
Bret Zeldow, James Flory, Alisa Stephens-Shields, Marsha Raebel, Jason A Roy
摘要
We develop a method to estimate subject-level trajectory functions from longitudinal data. The approach can be used for patient phenotyping, feature extraction, or, as in our motivating example, outcome identification, which refers to the process of identifying disease status through patient laboratory tests rather than through diagnosis codes or prescription information. We model the joint distribution of a continuous longitudinal outcome and baseline covariates using an enriched Dirichlet process prior. This joint model decomposes into (local) semiparametric linear mixed models for the outcome given the covariates and simple (local) marginals for the covariates. The nonparametric enriched Dirichlet process prior is placed on the regression and spline coefficients, the error variance, and the parameters governing the predictor space. This leads to clustering of patients based on their outcomes and covariates. We predict the outcome at unobserved time points for subjects with data at other time points as well as for new subjects with only baseline covariates. We find improved prediction over mixed models with Dirichlet process priors when there are a large number of covariates. Our method is demonstrated with electronic health records consisting of initiators of second-generation antipsychotic medications, which are known to increase the risk of diabetes. We use our model to predict laboratory values indicative of diabetes for each individual and assess incidence of suspected diabetes from the predicted dataset.
SiM Clinical Trials Causal Inference · 发表于 2020-11-10
Yu Shi, Briana Cameron, Xian Gu, Michael Kane, Peter Peduzzi, Denise A. Esserman
摘要
While the traditional clinical trial design lays emphasis on testing the treatment effect between randomly assigned groups, it ignores the role of patient preference for a particular treatment in the trial. Yet, for healthcare providers who seek to optimize the patient‐centered treatment strategy, the evaluation of a patient's psychology toward each treatment could be a key consideration. The two‐stage randomized trial design allows researchers to test patient's preference and selection effects, in addition to the treatment effect. The current methodology for the two‐stage design is limited to continuous and binary outcomes; this article extends the model to include count outcomes. The test statistics for preference, selection, and treatment effects are derived. Closed‐form sample size formulae are presented for each effect. Simulations are presented to demonstrate the properties of the unstratified and stratified designs. Finally, we apply methods to the use of antimicrobials at the end of life to demonstrate the applicability of the methods.
SiM Clinical Trials Causal Inference · 发表于 2020-11-10
Shuxi Zeng, Fan Li, Rui Wang, Fan Li
摘要
Chance imbalance in baseline characteristics is common in randomized clinical trials. Regression adjustment such as the analysis of covariance (ANCOVA) is often used to account for imbalance and increase precision of the treatment effect estimate. An objective alternative is through inverse probability weighting (IPW) of the propensity scores. Although IPW and ANCOVA are asymptotically equivalent, the former may demonstrate inferior performance in finite samples. In this article, we point out that IPW is a special case of the general class of balancing weights, and advocate to use overlap weighting (OW) for covariate adjustment. The OW method has a unique advantage of completely removing chance imbalance when the propensity score is estimated by logistic regression. We show that the OW estimator attains the same semiparametric variance lower bound as the most efficient ANCOVA estimator and the IPW estimator for a continuous outcome, and derive closed‐form variance estimators for OW when estimating additive and ratio estimands. Through extensive simulations, we demonstrate OW consistently outperforms IPW in finite samples and improves the efficiency over ANCOVA and augmented IPW when the degree of treatment effect heterogeneity is moderate or when the outcome model is incorrectly specified. We apply the proposed OW estimator to the Best Apnea Interventions for Research (BestAIR) randomized trial to evaluate the effect of continuous positive airway pressure on patient health outcomes. All the discussed propensity score weighting methods are implemented in the R package PSweight.
SiM Other · 发表于 2020-11-10
Ernesto J. Veres‐Ferrer, Jose M. Pavía
摘要
The correct identification of change‐points during ongoing outbreak investigations of infectious diseases is a matter of paramount importance in epidemiology, with major implications for the management of health care resources, public health and, as the COVID‐19 pandemic has shown, social live. Onsets, peaks, and inflexion points are some of them. An onset is the moment when the epidemic starts. A "peak" indicates a moment at which the incorporated values, both before and after, are lower: a maximum. The inflexion points identify moments in which the rate of growth of the incorporation of new cases changes intensity. In this study, after interpreting the concept of elasticity of a random variable in an innovative way, we propose using it as a new simpler tool for anticipating epidemic remission change‐points. In particular, we propose that the "remission point of change" will occur just at the instant when the speed in the accumulation of new cases is lower than the average speed of accumulation of cases up to that moment. This gives stability and robustness to the estimation in the event of possible remission variations. This descriptive measure, which is very easy to calculate and interpret, is revealed as informative and adequate, has the advantage of being distribution‐free and can be estimated in real time, while the data is being collected. We use the 2014‐2016 Western Africa Ebola virus epidemic to demonstrate this new approach. A couple of examples analyzing COVID‐19 data are also included.